By a few weeks. Is it a big deal?
I don’t see how it is embarrassing in any way.
Antigen is just one part of AT1’s business. It might take them a little time to make applications, at the cost of developing their whole business. 3 new patents, HIV, Febridx, OHM, a lot more going on.
I’m fine with a later approval than Patonic that if it means they have a diversified income stream.
Media Update, page-1246
-
- There are more pages in this discussion • 600 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $3.016K | 150.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628443 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 291292 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |